Literature DB >> 12407365

The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation.

David P Vogt1, J Michael Henderson, William D Carey, David Barnes.   

Abstract

BACKGROUND: The purpose of this study was to examine the long-term survival and causes of death in patients who survive the first year after liver transplantation.
METHODS: The focus of the analysis was 433 patients who survived for at least 1 year after liver transplantation between November 1, 1984, and December 31, 2001. A total of 586 liver transplants were performed in 542 patients during this time period. The overall 1-, 5-, and 10-year survivals and the 5- and 10-year survivals for those patients who lived for a year were analyzed on the basis of Kaplan-Meier survival estimates. Factors examined included diagnosis, sex, age, and retransplantation. The causes of death were also analyzed.
RESULTS: The overall 1-, 5-, and 10-year survivals were 85%, 73%, and 55%, respectively. The 5- and 10-year survivals for those patients who lived for a year were 86% and 65%, respectively. Fifty-one percent of the causes of late death were graft-related, 71% from recurrent primary disease. Cardiovascular events and de novo malignancies were responsible for 65% of the nongraft-related deaths.
CONCLUSIONS: The long-term survival in patients who survive for the first year after liver transplantation is excellent. Recurrent primary disease is responsible for the majority of graft-related deaths. Cardiovascular events and de novo malignancy cause most of the nongraft-related deaths.

Entities:  

Mesh:

Year:  2002        PMID: 12407365     DOI: 10.1067/msy.2002.128343

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  13 in total

Review 1.  Developments in liver transplantation.

Authors:  J Neuberger
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

2.  Office-Based Weight Loss Counseling Is Ineffective in Liver Transplant Recipients.

Authors:  Samarth S Patel; Mohammad B Siddiqui; Anchalia Chadrakumaran; Masoud Faridnia; Fei-Pi Lin; Jose Hernandez Roman; Salvatore Carbone; John Laurenzo; Joseph Clinton; Danielle Kirkman; Susan Wolver; Francesco Celi; Chandra Bhati; Mohammad S Siddiqui
Journal:  Dig Dis Sci       Date:  2019-08-22       Impact factor: 3.199

3.  Decision tree analysis to stratify risk of de novo non-melanoma skin cancer following liver transplantation.

Authors:  Tomohiro Tanaka; Michael D Voigt
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-23       Impact factor: 4.553

4.  Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplant.

Authors:  Kiran Bambha; W Ray Kim; Charles B Rosen; Rachel A Pedersen; Cynthia Rys; Christopher P Kolbert; Julie M Cunningham; Terry M Therneau
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

Review 5.  Predictive roles of intraoperative blood glucose for post-transplant outcomes in liver transplantation.

Authors:  Chul Soo Park
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

6.  SPECT myocardial perfusion imaging in liver transplantation candidates.

Authors:  W Lane Duvall; Aditi Singhvi; Nidhi Tripathi; Milena J Henzlova
Journal:  J Nucl Cardiol       Date:  2018-08-23       Impact factor: 5.952

Review 7.  Metabolic complications in liver transplant recipients.

Authors:  Miguel Jiménez-Pérez; Rocío González-Grande; Edith Omonte Guzmán; Víctor Amo Trillo; Juan Miguel Rodrigo López
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

8.  CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.

Authors:  L Quteineh; P-Y Bochud; D Golshayan; S Crettol; J-P Venetz; O Manuel; Z Kutalik; A Treyer; R Lehmann; N J Mueller; I Binet; C van Delden; J Steiger; P Mohacsi; J-F Dufour; P M Soccal; M Pascual; C B Eap
Journal:  Pharmacogenomics J       Date:  2015-12-08       Impact factor: 3.550

9.  Sluggish decline in a post-transplant model for end-stage liver disease score is a predictor of mortality in living donor liver transplantation.

Authors:  Won Jung Hwang; Joon Pyo Jeon; Seung Hee Kang; Hyun Sik Chung; Ji Yong Kim; Chul Soo Park
Journal:  Korean J Anesthesiol       Date:  2010-09-20

10.  Posttransplant metabolic syndrome.

Authors:  M Shadab Siddiqui; Richard K Sterling
Journal:  Int J Hepatol       Date:  2012-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.